{"id":"https://openalex.org/W2397917110","doi":"https://doi.org/10.2217/rme-2016-0010","title":"Gene Therapies: The Challenge of sUper-High-Cost Treatments and How to Pay for them","display_name":"Gene Therapies: The Challenge of sUper-High-Cost Treatments and How to Pay for them","publication_year":2016,"publication_date":"2016-05-17","ids":{"openalex":"https://openalex.org/W2397917110","doi":"https://doi.org/10.2217/rme-2016-0010","mag":"2397917110","pmid":"https://pubmed.ncbi.nlm.nih.gov/27185544"},"language":"en","primary_location":{"id":"doi:10.2217/rme-2016-0010","doi":"https://doi.org/10.2217/rme-2016-0010","is_oa":false,"landing_page_url":"https://doi.org/10.2217/rme-2016-0010","pdf_url":null,"source":{"id":"https://openalex.org/S156036346","display_name":"Regenerative Medicine","issn_l":"1746-0751","issn":["1746-0751","1746-076X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regenerative Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David R Carr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R Carr","raw_affiliation_strings":["Valid Insight, Kemp House, 152 City Road, Islington, London, EC1V 2NX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valid Insight, Kemp House, 152 City Road, Islington, London, EC1V 2NX, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067948014","display_name":"Steven E. Bradshaw","orcid":"https://orcid.org/0000-0002-3080-2827","observed_orcids":["https://orcid.org/0000-0002-3080-2827"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Steven E Bradshaw","raw_affiliation_strings":["Valid Insight, Kemp House, 152 City Road, Islington, London, EC1V 2NX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valid Insight, Kemp House, 152 City Road, Islington, London, EC1V 2NX, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5067948014"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7865,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.95684201,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"11","issue":"4","first_page":"381","last_page":"393"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5189999938011169},{"id":"https://openalex.org/keywords/payment-models","display_name":"payment models","score":0.5950000286102295},{"id":"https://openalex.org/keywords/reimbursement","display_name":"reimbursement","score":0.8360000252723694},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.7139999866485596},{"id":"https://openalex.org/keywords/access-to-treatment","display_name":"access to treatment","score":0.5210000276565552},{"id":"https://openalex.org/keywords/health-budget","display_name":"health budget","score":0.6759999990463257},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.8733316659927368},{"id":"https://openalex.org/C145097563","wikidata":"https://www.wikidata.org/wiki/Q1148747","display_name":"Payment","level":2,"score":0.6354559659957886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46497631072998047},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4507359564304352},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.45034852623939514},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4189176559448242},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.35172411799430847},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.28191637992858887},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.20763945579528809},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.17960849404335022}],"mesh":[{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012052","descriptor_name":"Reimbursement, Incentive","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2217/rme-2016-0010","doi":"https://doi.org/10.2217/rme-2016-0010","is_oa":false,"landing_page_url":"https://doi.org/10.2217/rme-2016-0010","pdf_url":null,"source":{"id":"https://openalex.org/S156036346","display_name":"Regenerative Medicine","issn_l":"1746-0751","issn":["1746-0751","1746-076X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regenerative Medicine","raw_type":"journal-article"},{"id":"pmid:27185544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27185544","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regenerative medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W201064510","https://openalex.org/W1162328122","https://openalex.org/W1513289554","https://openalex.org/W1719302829","https://openalex.org/W1869769934","https://openalex.org/W1871133047","https://openalex.org/W1882758100","https://openalex.org/W1969011049","https://openalex.org/W1969229533","https://openalex.org/W1984005894","https://openalex.org/W1984672300","https://openalex.org/W1985882520","https://openalex.org/W1990800143","https://openalex.org/W2011819438","https://openalex.org/W2012670419","https://openalex.org/W2019564656","https://openalex.org/W2019716535","https://openalex.org/W2032000610","https://openalex.org/W2034022408","https://openalex.org/W2051788045","https://openalex.org/W2062569630","https://openalex.org/W2083456790","https://openalex.org/W2093284460","https://openalex.org/W2112431056","https://openalex.org/W2112942078","https://openalex.org/W2124963528","https://openalex.org/W2131080517","https://openalex.org/W2147886756","https://openalex.org/W2158780781","https://openalex.org/W2172957160","https://openalex.org/W2343495932"],"related_works":["https://openalex.org/W4388408638","https://openalex.org/W4404388316","https://openalex.org/W2995884588","https://openalex.org/W2994882686","https://openalex.org/W2899450784","https://openalex.org/W3095821856","https://openalex.org/W4399971723","https://openalex.org/W2901054845","https://openalex.org/W2765094287","https://openalex.org/W7125496698"],"abstract_inverted_index":{"Gene":[0],"therapies":[1,116],"have":[2,11],"the":[3,35,66,75],"potential":[4,56],"to":[5,58,112,118],"cure":[6],"rare":[7],"conditions":[8],"that":[9,97],"often":[10],"no":[12],"current":[13],"efficacious":[14],"treatments":[15],"with":[16,34],"a":[17,55],"one-time":[18],"treatment":[19],"episode,":[20],"relieving":[21],"substantial":[22],"unmet":[23],"need":[24],"and":[25,41,50,85,107,117],"having":[26],"profound":[27],"positive":[28],"impact":[29],"on":[30],"patients'":[31],"lives.":[32],"However,":[33],"first":[36],"gene":[37,71,115],"therapy":[38],"now":[39],"licensed":[40],"priced":[42],"at":[43,83],"around":[44],"US$1":[45],"million":[46],"per":[47],"patient,":[48],"cost":[49],"uncertain":[51],"funding":[52],"mechanisms":[53],"present":[54,93],"barrier":[57],"patient":[59],"access.":[60],"In":[61],"this":[62],"article,":[63],"we":[64],"discuss":[65],"unique":[67],"challenges":[68],"presented":[69],"by":[70],"therapies,":[72],"particularly":[73],"concerning":[74],"uncertainty":[76],"inherent":[77],"in":[78],"their":[79,86],"clinical":[80],"evidence":[81],"package":[82],"launch":[84],"affordability":[87],"within":[88],"strained":[89],"healthcare":[90],"budgets.":[91],"We":[92],"several":[94],"payment":[95],"models":[96],"would":[98],"allow":[99],"for":[100,121],"sustainable":[101],"reimbursement":[102],"of":[103],"these":[104],"innovative":[105],"technologies":[106],"make":[108],"recommendations":[109],"pertinent":[110],"both":[111],"those":[113,119],"developing":[114],"paying":[120],"them.":[122]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}